NCT06156527 2023-12-05A Randomized Phase II Study of LAZE rtiNib Alone Versus Lazertinib Plus bevaCizumab for NSCLC With EGFR + & SmokerNational Cancer Center, KoreaPhase 2 Recruiting120 enrolled